StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ:BLPH opened at $0.04 on Wednesday. The firm has a market cap of $440,388.00, a PE ratio of -0.04 and a beta of 0.70. The firm’s 50 day simple moving average is $0.04 and its 200-day simple moving average is $0.05. Bellerophon Therapeutics has a one year low of $0.03 and a one year high of $0.10.
About Bellerophon Therapeutics
Featured Stories
- Five stocks we like better than Bellerophon Therapeutics
- Bank Stocks – Best Bank Stocks to Invest In
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Manufacturing Stocks Investing
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Stock Splits, Do They Really Impact Investors?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.